Skip to main content
Recent Patents on Cardiovascular Drug Discovery publishes review articles on recent patents in the field of cardiovascular drug discovery e.g. novel bioactive compounds, analogs & targets. A selection of important and recent patents on cardiovascular drug discovery is also included in the journal. The journal is essential reading for all researchers involved in cardiovascular drug design and discovery.

Publisher: Bentham Science Publishers

Volume 1, Number 3, 2006

Articles

The Renin Inhibitor Aliskiren as Novel Treatment for Cardiovascular Disease
pp. 233-240(8)
Authors: Saez, Anabelle O.; Philipp, Thomas; Nurnberger, Jens

Favourites:
ADD

TP Receptor as a Therapeutic Target in Atherosclerosis and Related Cardiovascular Diseases
pp. 241-247(7)
Authors: Ishizuka, Toshiaki; Higashino, Hideaki

Favourites:
ADD
Favourites:
ADD

Recent Developments on Endothelin Antagonists as Immunomodulatory Drugs - from Infection to Transplantation Medicine
pp. 265-276(12)
Authors: Nett, Philipp C.; Teixeira, Mauro M.; Candinas, Daniel; Barton, Matthias

Favourites:
ADD

Ivabradine: a Selective If Current Inhibitor in the Treatment of Stable Angina
pp. 277-282(6)
Authors: Andrikopoulos, George; Dasopoulou, Chryssanthi; Sakellariou, Dimitris; Tzeis, Stylianos; Koulouris, Spyridon; Kranidis, Athanasios; Kappos, Kostas; Manolis, Antonis S.

Favourites:
ADD

Role of Perindopril in the Prevention of Stroke
pp. 283-289(7)
Authors: Papadopoulos, Dimitris P.; Votteas, Vasilios

Favourites:
ADD
Favourites:
ADD

Recent Developments in Antithrombotic Therapy: Will Sodium Warfarin Be a Drug of the Past?
pp. 307-316(10)
Authors: Desai, Sapan S.; Massad, Malek G.; DiDomenico, Robert J.; Abdelhady, Khaled; Hanhan, Ziad; Lele, Himalaya; Snow, Norman J.; Geha, Alexander S.

Favourites:
ADD

Patent Annotations
pp. 317-319(3)

Favourites:
ADD

Patent Selections
pp. 321-327(7)

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content